{
    "clinical_study": {
        "@rank": "127727", 
        "acronym": "DMD", 
        "arm_group": [
            {
                "arm_group_label": "VECTTOR", 
                "arm_group_type": "Experimental", 
                "description": "muscle stimulator treatment twice daily for duration of study - 365 days"
            }, 
            {
                "arm_group_label": "Device - sham", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo treatment - no electrical stimulation treatment twice daily for duration of study, 365 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this investigation is to assess the effectiveness of transcutaneous\n      electrical nerve stimulation applied using VECTTOR to reduce the symptoms of Duchenne\n      Muscular Dystrophy and reduce the impact of DMD upon the participants' quality of life.\n\n      The primary outcome measures will include:\n\n        1. increased muscle strength and\n\n        2. increased range of joint motions."
        }, 
        "brief_title": "Duchenne Muscular Dystrophy Clinical Trial", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Duchenne Muscular Dystrophy", 
        "condition_browse": {
            "mesh_term": [
                "Muscular Dystrophy, Duchenne", 
                "Muscular Dystrophies"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants must have Duchenne Muscular Dystrophy diagnosis as confirmed by licensed\n             physician, wheelchair bound, & age 15-20 years old.\n\n        Exclusion Criteria:\n\n          -  Active cancer in the area of application of the treatment, infection, skin infection,\n             pregnancy, thrombophlebitis, pacemaker, amputation of any part of feet or hands,\n             taking steroids.  In addition, the participant may not be in any other clinical trial\n             during the time they are in this study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "20 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874275", 
            "org_study_id": "VECTTOR DMD2012"
        }, 
        "intervention": {
            "arm_group_label": [
                "VECTTOR", 
                "Device - sham"
            ], 
            "description": "The VT-200, or VECTTOR system, delivers electrical stimulation via electrodes on the acupuncture points of a patient's feet/legs and hands/arms to provide symptomatic relief of chronic intractable pain and/or management of post-surgical pain.\nOnce these electrodes are placed, the machine determines the appropriate choice of stimulation by automatically measuring body temperatures through the use of thermistors placed on the fingers during a testing sequence.", 
            "intervention_name": "VECTTOR", 
            "intervention_type": "Device", 
            "other_name": "electrical muscle stimulator"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "June 10, 2013", 
        "location": {
            "contact": {
                "email": "DrRhodes2@aol.com", 
                "last_name": "Donald Rhodes, MD", 
                "phone": "361-992-9432"
            }, 
            "contact_backup": {
                "email": "jheinrich4@comcast.net", 
                "last_name": "Joyce Heinrich", 
                "phone": "713-734-4433"
            }, 
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77004"
                }, 
                "name": "Pediatric Physical Medicine and Rehabilitation"
            }, 
            "investigator": {
                "last_name": "Charlotte Stelly-Seitz, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Double-blind, Randomized, Placebo-controlled Study of VECTTOR Treatment for Duchenne Muscular Dystrophy", 
        "other_outcome": {
            "description": "Sleep Studies will be obtained twice before beginning the study.  The second study will be used as the baseline test.", 
            "measure": "improvement of sleep quality", 
            "safety_issue": "No", 
            "time_frame": "assessed at 90, 180 and 365 days"
        }, 
        "overall_contact": {
            "email": "DrRhodes2@aol.com", 
            "last_name": "Donald Rhodes, MD", 
            "phone": "361-992-9432"
        }, 
        "overall_contact_backup": {
            "email": "jheinrich4@comcast.net", 
            "last_name": "Joyce Heinrich", 
            "phone": "713-734-4433"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Range of motion testing (Wireless Tracker System)", 
            "measure": "Increased range of motion", 
            "safety_issue": "No", 
            "time_frame": "measurements aassessed at intervals of 30, 60, 90, 180 and 360 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874275"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Muscle strength testing (Wireless Tracker system)", 
            "measure": "Increased muscle strength", 
            "safety_issue": "No", 
            "time_frame": "measurement assessed at intervals of 30, 60, 90 180 and 360 days"
        }, 
        "source": "Alan Neuromedical Technologies, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alan Neuromedical Technologies, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}